[HTML] nih.gov

Persistence and adherence to interferon and glatiramer acetate in patients with multiple sclerosis

E Bartolomé-García, Á Usarralde-Pérez… - European Journal of …, 2019 - ejhp.bmj.com
Objectives To analyse persistence and adherence in patients with multiple sclerosis
receiving first-line treatment with subcutaneous glatiramer acetate 20 mg (GA) …
Save Cite Cited by 12 Related articles All 7 versions

[CITATION][C] Linagliptin-induced liver toxicity

E Bartolomé-García, S Sanz-Márquez… - … : Organo Oficial de …, 2017 - europepmc.org
[Linagliptin-induced liver toxicity]. - Abstract - Europe PMC Sign in | Create an account https://orcid.org
Europe PMC Menu About Tools Developers Help Contact us Helpdesk Feedback Twitter …
Save Cite Related articles All 2 versions Cached
[PDF] sefh.es

[PDF][PDF] HOSPITALARIA

E Bartolomé-García, S Sanz-Márquez… - sefh.es
Linagliptina es un antidiabético oral inhibidor de la enzima dipeptidil peptidasa 4 (DPP-4)
indicado en la diabetes mellitus tipo 2 (DM2), ya sea en monoterapia, asociada a …
Save Cite Related articles View as HTML
[HTML] isciii.es

[HTML][HTML] Hepatitis tóxica por linagliptina

E Bartolomé-García, S Sanz-Márquez… - Farmacia …, 2017 - SciELO Espana
Hepatitis tóxica por linagliptina SciELO - Scientific Electronic Library Online vol.41 número4
Reacción paradójica psoriaforme por infliximab Asistolia tras la administración de regadenosón …
Save Cite Related articles All 10 versions Cached
[PDF] sefh.es

[PDF][PDF] Hepatitis tóxica por linagliptina Linagliptin-induced liver toxicity

E Bartolomé-García, S Sanz-Márquez… - HOSPITALARIA - sefh.es
Linagliptina es un antidiabético oral inhibidor de la enzima dipeptidil peptidasa 4 (DPP-4)
indicado en la diabetes mellitus tipo 2 (DM2), ya sea en monoterapia, asociada a …
Save Cite Related articles All 4 versions View as HTML